X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (67) 67
urology & nephrology (66) 66
human necessities (61) 61
hygiene (61) 61
medical or veterinary science (61) 61
devices for introducing media into, or onto, the body (51) 51
devices for producing or ending sleep or stupor (51) 51
devices for transducing body media or for taking media fromthe body (51) 51
preparations for medical, dental, or toilet purposes (51) 51
male (37) 37
female (35) 35
middle aged (31) 31
index medicus (30) 30
aged (24) 24
peritoneal dialysis (24) 24
transplantation (24) 24
biocompatibility (21) 21
adult (19) 19
hydrogen-ion concentration (18) 18
animals (17) 17
glucose degradation products (17) 17
specific therapeutic activity of chemical compounds ormedicinal preparations (17) 17
kidney failure, chronic - therapy (16) 16
nephrology (16) 16
cells, cultured (15) 15
dialysis solutions - pharmacology (15) 15
general tagging of cross-sectional technologies spanning over several sections of the ipc (15) 15
general tagging of new technological developments (15) 15
hemodialysis (15) 15
technical subjects covered by former uspc (15) 15
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (15) 15
glucose - metabolism (14) 14
hemodialysis-patients (14) 14
peritoneal dialysis, continuous ambulatory (14) 14
dialysis solutions - chemistry (13) 13
rats (13) 13
buffers (12) 12
in-vitro (11) 11
capd (10) 10
chemical or physical processes, e.g. catalysis or colloidchemistry (10) 10
performing operations (10) 10
physical or chemical processes or apparatus in general (10) 10
rats, wistar (10) 10
their relevant apparatus (10) 10
transporting (10) 10
glycation end-products (9) 9
mortality (9) 9
peritoneum - drug effects (9) 9
technical subjects covered by former uspc cross-reference artcollections [xracs] and digests (9) 9
calcification (8) 8
calcium (8) 8
chemistry (8) 8
cross-over studies (8) 8
further section (8) 8
haemodialysis (8) 8
membrane (8) 8
metallurgy (8) 8
original (8) 8
peritoneum - metabolism (8) 8
phosphate (8) 8
aged, 80 and over (7) 7
bicarbonate (7) 7
dialysis solutions (7) 7
disease models, animal (7) 7
enzyme-linked immunosorbent assay (7) 7
fluid (7) 7
follow-up studies (7) 7
mesothelial cells (7) 7
parathyroid hormone - blood (7) 7
renal dialysis (7) 7
stage renal-disease (7) 7
time factors (7) 7
transport (7) 7
adolescent (6) 6
calcium - blood (6) 6
chronic kidney-disease (6) 6
cohort studies (6) 6
dialysis solutions - adverse effects (6) 6
expression (6) 6
glucose - pharmacology (6) 6
in vitro techniques (6) 6
inhibition (6) 6
investigating or analysing materials by determining theirchemical or physical properties (6) 6
kidney failure, chronic - blood (6) 6
kidney failure, chronic - physiopathology (6) 6
lactate (6) 6
magnesium (6) 6
magnesium - pharmacology (6) 6
measuring (6) 6
peritoneal dialysis, continuous ambulatory - methods (6) 6
peritoneum - cytology (6) 6
physics (6) 6
renal dialysis - adverse effects (6) 6
technical subjects covered by former us classification (6) 6
testing (6) 6
vascular calcification (6) 6
biocompatible materials (5) 5
capd patients (5) 5
chronic-renal-failure (5) 5
dialysis solutions - administration & dosage (5) 5
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (163) 163
French (31) 31
German (30) 30
Spanish (8) 8
Chinese (5) 5
Portuguese (2) 2
Danish (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 01/2015, Volume 10, Issue 1, p. e0115342
Background Cardiovascular disease including vascular calcification (VC) remains the leading cause of death in patients suffering from chronic kidney disease... 
YOUNG-ADULTS | IN-VITRO | UREMIA | INDUCED CALCIFICATION | CORONARY | MULTIDISCIPLINARY SCIENCES | GROWTH | INFRARED-SPECTROSCOPY | CHRONIC KIDNEY-DISEASE | STAGE RENAL-DISEASE | CHRONIC DIALYSIS PATIENTS | Humans | Cells, Cultured | Myocytes, Smooth Muscle - pathology | Magnesium - metabolism | Male | Aorta - metabolism | Vascular Calcification - pathology | Renal Insufficiency, Chronic - pathology | Aorta - pathology | Renal Insufficiency, Chronic - metabolism | Vascular Calcification - metabolism | Female | Calcium Phosphates - metabolism | Myocytes, Smooth Muscle - metabolism | Phosphate minerals | Chronic kidney failure | Analysis | Phosphate rock | Crystals | Smooth muscle | Calcium phosphate | Precipitation (Meteorology) | Structure | Calcification (ectopic) | Phosphates | Crystal growth | Infrared spectroscopy | Animal models | Fourier transforms | Calcium | Syngeneic grafts | Iron | Hydroxyapatite | Spectrometry | Maps | Rodents | Atherosclerosis | Spots | Aorta | Qualitative analysis | Supplementation | Magnesium | Crystal structure | Scanning electron microscopy | Young adults | Chemical precipitation | Muscles | Patients | Calcium phosphates | Studies | Microscopy | Coronary vessels | Calcification | Apatite | Kidney diseases | Cardiovascular diseases | Kidney transplantation | Veins & arteries | Life Sciences | Human health and pathology
Journal Article
Kidney International, ISSN 0085-2538, 07/2004, Volume 66, Issue 1, pp. 408 - 418
Journal Article
PloS one, ISSN 1932-6203, 2014, Volume 9, Issue 2, p. e89525
Magnesium reduces vascular smooth muscle cell (VSMC) calcification in vitro but the mechanism has not been revealed so far. This work used only slightly... 
SEVELAMER | HOMEOSTASIS | CORONARY-ARTERY CALCIFICATION | BINDER | MULTIDISCIPLINARY SCIENCES | CALCIUM | HEMODIALYSIS-PATIENTS | PARATHYROID-HORMONE | OSTEOPROTEGERIN | PHOSPHATE-INDUCED CALCIFICATION | MODULATION | Muscle, Smooth, Vascular - metabolism | Humans | Protein-Serine-Threonine Kinases | Wnt Proteins - metabolism | Vascular Calcification - metabolism | Wnt Proteins - genetics | Osteoprotegerin - genetics | Real-Time Polymerase Chain Reaction | Extracellular Matrix Proteins - metabolism | Muscle, Smooth, Vascular - drug effects | Calcium-Binding Proteins - metabolism | Boron Compounds - pharmacology | Extracellular Matrix Proteins - genetics | Osteogenesis - drug effects | RNA, Messenger - genetics | Cells, Cultured | Vascular Calcification - drug therapy | Magnesium - pharmacology | Muscle, Smooth, Vascular - cytology | Reverse Transcriptase Polymerase Chain Reaction | beta Catenin - metabolism | beta Catenin - genetics | TRPM Cation Channels - antagonists & inhibitors | Signal Transduction - drug effects | beta Catenin - antagonists & inhibitors | TRPM Cation Channels - genetics | TRPM Cation Channels - metabolism | Osteoprotegerin - metabolism | Wnt Proteins - antagonists & inhibitors | Calcium-Binding Proteins - genetics | Calcification (ectopic) | Phosphates | Transformation | Transcription factors | Wnt protein | Calcium | Frizzled protein | Homeostasis | Smooth muscle | Activation | Kinases | Osteoprotegerin | Proteins | Transient receptor potential proteins | β-catenin | Signal transduction | Biomedical materials | Biocompatibility | Magnesium | Inhibition | Translocation | Cbfa-1 protein | Muscles | siRNA | Gene expression | Studies | Signaling | Lymphocytes B | Calcification | Transport | Dkk1 protein | Apoptosis
Journal Article
Kidney International, ISSN 0085-2538, 06/2013, Volume 83, Issue 6, pp. 1109 - 1117
Calcium-based phosphate binders are used to control hyperphosphatemia; however, they promote hypercalcemia and may accelerate aortic calcification. Here we... 
phosphate binders | hyperphosphatemia | vascular calcification | Hyperphosphatemia | Vascular calcification | Phosphate binders | CALCIUM-CARBONATE | SERUM MAGNESIUM | INHIBITION | PROFILE | ARTERIAL CALCIFICATION | HEMODIALYSIS-PATIENTS | UROLOGY & NEPHROLOGY | CHRONIC KIDNEY-DISEASE | BINDING | SEVELAMER HYDROCHLORIDE | Rats, Wistar | Vascular Calcification - genetics | Aortic Diseases - blood | Male | Parathyroid Hormone - blood | Dose-Response Relationship, Drug | Calcium - blood | Hyperphosphatemia - blood | Time Factors | Vascular Calcification - etiology | Bone Morphogenetic Protein 2 - metabolism | Kidney Failure, Chronic - chemically induced | Aortic Diseases - prevention & control | Phosphates - blood | Sevelamer | Extracellular Matrix Proteins - metabolism | Aortic Diseases - pathology | Calcium Compounds - pharmacology | Disease Models, Animal | Calcium-Binding Proteins - metabolism | SOX9 Transcription Factor - metabolism | Bone Morphogenetic Protein 2 - genetics | Extracellular Matrix Proteins - genetics | Vascular Calcification - blood | Gene Expression Regulation | Adenine | Rats | Vascular Calcification - prevention & control | Chelating Agents - pharmacology | Magnesium - pharmacology | Vascular Calcification - pathology | Aortic Diseases - genetics | Polyamines - pharmacology | Animals | Kidney Failure, Chronic - blood | Hyperphosphatemia - etiology | Uremia - blood | Kidney Failure, Chronic - complications | Hyperphosphatemia - drug therapy | Acetates - pharmacology | Uremia - etiology | SOX9 Transcription Factor - genetics | Aortic Diseases - etiology | Calcium-Binding Proteins - genetics | Basic Research
Journal Article
Artificial Organs, ISSN 0160-564X, 04/2013, Volume 37, Issue 4, pp. 409 - 416
Journal Article